JANUS HENDERSON GROUP PLC purchased 11.6% of their position (220.08K shares) of ORUKA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $699.2K — a moderate purchase. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 7/26/2024ACC: 0001437749-24-023533
10% Owner
Since Jul 2024
+220.08K
Net shares
Net buyer
$699.2K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
220.08K acquired
Non-Derivative Transactions4
Common Stock
Indirect
Shares
+165K
Price / share
$3.20
Trade value
$528K
% of position
8.7%
7/24/2024
1.89M→2.06M
Common Stock
Indirect
Shares
+17.80K
Price / share
$3.18
Trade value
$56.60K
% of position
0.9%
7/24/2024
2.06M→2.07M
Common Stock
Indirect
Shares
+7.06K
Price / share
$3.16
Trade value
$22.28K
% of position
0.3%
7/24/2024
2.07M→2.08M
Common Stock
Indirect
Shares
+30.23K
Price / share
$3.05
Trade value
$92.29K
% of position
1.5%
7/25/2024
2.08M→2.11M
Total
Net shares
+220.08K
Net value
$699.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/24/2024 | P · Purchase | +165K | $3.20 | $528K | 8.7% | 1.89M | 2.06M |
| Common Stock Indirect | 7/24/2024 | P · Purchase | +17.80K | $3.18 | $56.60K | 0.9% | 2.06M | 2.07M |
| Common Stock Indirect | 7/24/2024 | P · Purchase | +7.06K | $3.16 | $22.28K | 0.3% | 2.07M | 2.08M |
| Common Stock Indirect | 7/25/2024 | P · Purchase | +30.23K | $3.05 | $92.29K | 1.5% | 2.08M | 2.11M |
| Total | +220.08K | $699.17K | ||||||
Derivative Transactions0
No derivative transactions reported